Pore-forming proteins and their role in cancer and inflammation: Mechanistic insights and plausible druggable targets

dc.contributor.authorSankar, Jishnu
dc.contributor.authorArora, Sahil
dc.contributor.authorJoshi, Gaurav
dc.contributor.authorKumar, Raj
dc.date.accessioned2024-01-21T10:38:24Z
dc.date.accessioned2024-08-13T12:05:20Z
dc.date.available2024-01-21T10:38:24Z
dc.date.available2024-08-13T12:05:20Z
dc.date.issued2022-08-30T00:00:00
dc.description.abstractPerforin is a granular effector pore-forming protein formed in NK cells and Cytotoxic T lymphocytes. These cytotoxic proteins are part of the first-line immune defense in the human body. They ensure apoptosis of pathogen-infected cells or tumor cells in the human body. Activation of receptors on NK cell or T cell triggers secondary proteins in these cells. Further, it leads to Ca2+ dependent perforin egress towards the target cell, ensued by PI3K signaling pathway. Perforin undergoes oligomerization over the target cell membrane and forms transmembrane pores with the membrane-spanning domain-MACPF domain. Granzymes, proapoptotic serine proteases are released through these pores and initiate the target cell apoptotic pathway leading to the cell death. Although perforin is a savior for humans from tumor and viral infections, uncontrolled expression of the perforins leads to the autoimmune conditions, including Familial Hemophagocytic lymphohistiocytosis, insulin-dependent diabetes, and cerebral myocarditis. The present review is the concerted effort to highlight the mechanistic pathways concerning perforin secretion, NK cell and T cell-mediated cytotoxicity towards virus-infected and transformed cells. This is followed by the discussion on synthetic derivatives tested so far to inhibit the perforin in pre and clinical arena for certain unusual conditions. � 2022 Elsevier B.V.en_US
dc.identifier.doi10.1016/j.cbi.2022.110127
dc.identifier.issn92797
dc.identifier.urihttps://kr.cup.edu.in/handle/32116/3560
dc.identifier.urlhttps://linkinghub.elsevier.com/retrieve/pii/S0009279722003325
dc.language.isoen_USen_US
dc.publisherElsevier Ireland Ltden_US
dc.subjectCanceren_US
dc.subjectDrug developmenten_US
dc.subjectImmunologyen_US
dc.subjectKiller cellsen_US
dc.subjectPerforinsen_US
dc.titlePore-forming proteins and their role in cancer and inflammation: Mechanistic insights and plausible druggable targetsen_US
dc.title.journalChemico-Biological Interactionsen_US
dc.typeReviewen_US
dc.type.accesstypeClosed Accessen_US

Files